# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-093221
Filing Date
2024-04-11
Accepted
2024-04-11 16:10:56
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d500367ddefa14a.htm | DEFA14A | 11186
2 | GRAPHIC | g500367g01dsp1.jpg | GRAPHIC | 9228
3 | GRAPHIC | g500367g02m00.jpg | GRAPHIC | 399816
4 | GRAPHIC | g500367g03a01.jpg | GRAPHIC | 370809
| Complete submission text file | 0001193125-24-093221.txt |  | 1086657

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 24838632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)